AbstractInteractions of protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) systems were investigated in HL60 cells. It was found that the differentiating effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) were potentiated by dibutyryl cAMP (dbcAMP) or prostaglandin E2 (PGE2). In addition, dbcAMP or PGE2 inhibited TPA-induced binding of PKC to plasma membrane, leading to decreased protein phosphorylation, and promoted subsequent redistribution of enzyme to the nuclear membrane region. The findings are consistent with the hypothesis that PKC and PKA systems regulate cooperatively the phenotypical differentiation of leukemic cells
Differentiation of human promyelocytic leukemia cells (HL-60) in response to several classes of indu...
Treatment of human promyelocytic leukemia cell HL60 with 12-o-tetradecanoylphorbol 13-acetate (TPA) ...
The human promyelocytic leukemia cell line HL-60 differentiates in vitro when treated with various i...
AbstractInteractions of protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) systems were ...
AbstractProtein kinase C (PKC) from human promyelocytic leukemia HL-60 cells can be resolved into th...
AbstractImmunocytochemical methods were used to study protein kinase C (PKC) distribution in HL60 ce...
Cyclic AMP (cAMP)-dependent protein kinase may play a role in the functional and morphological diffe...
AbstractImmunocytochemical methods were used to study protein kinase C (PKC) distribution in HL60 ce...
Two classes (site 1- and site 2-selective) of cAMP analogs, which either alone or in combination dem...
AbstractProtein kinase C (PKC) from human promyelocytic leukemia HL-60 cells can be resolved into th...
AbstractCytosol from untreated cells and a detergent extract of the particulate fraction from TPA-tr...
This thesis research characterizes the role of protein kinase C in 1,25-dihydroxyvitamin D$\sb3$ (1,...
AbstractExposure of HL-60 cells to subthreshold concentrations of TPA caused monocytic differentiati...
AbstractTreatment of human myeloid leukemic cells with phorbol esters such as 12-O-tetradecanoylphor...
AbstractPlasminogen activator (PA) activity of human promyelocytic leukemia cell line HL-60 was assa...
Differentiation of human promyelocytic leukemia cells (HL-60) in response to several classes of indu...
Treatment of human promyelocytic leukemia cell HL60 with 12-o-tetradecanoylphorbol 13-acetate (TPA) ...
The human promyelocytic leukemia cell line HL-60 differentiates in vitro when treated with various i...
AbstractInteractions of protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) systems were ...
AbstractProtein kinase C (PKC) from human promyelocytic leukemia HL-60 cells can be resolved into th...
AbstractImmunocytochemical methods were used to study protein kinase C (PKC) distribution in HL60 ce...
Cyclic AMP (cAMP)-dependent protein kinase may play a role in the functional and morphological diffe...
AbstractImmunocytochemical methods were used to study protein kinase C (PKC) distribution in HL60 ce...
Two classes (site 1- and site 2-selective) of cAMP analogs, which either alone or in combination dem...
AbstractProtein kinase C (PKC) from human promyelocytic leukemia HL-60 cells can be resolved into th...
AbstractCytosol from untreated cells and a detergent extract of the particulate fraction from TPA-tr...
This thesis research characterizes the role of protein kinase C in 1,25-dihydroxyvitamin D$\sb3$ (1,...
AbstractExposure of HL-60 cells to subthreshold concentrations of TPA caused monocytic differentiati...
AbstractTreatment of human myeloid leukemic cells with phorbol esters such as 12-O-tetradecanoylphor...
AbstractPlasminogen activator (PA) activity of human promyelocytic leukemia cell line HL-60 was assa...
Differentiation of human promyelocytic leukemia cells (HL-60) in response to several classes of indu...
Treatment of human promyelocytic leukemia cell HL60 with 12-o-tetradecanoylphorbol 13-acetate (TPA) ...
The human promyelocytic leukemia cell line HL-60 differentiates in vitro when treated with various i...